A protein on a cell structure called the primary cilia links diabetes and obesity. The discovery may lead to new diabetes treatments.
Stanford researchers and others created a project to increase the number of doctors who can provide diabetes care to underserved communities.
Stanford researchers find that screening all adults in the United States one time for hepatitis B could save money and lives.
Stanford Medicine researchers discover that the virus behind COVID-19 attacks insulin-producing cells in the pancreas.
As more children and teens with diabetes use technology to treat the disease, U.S. kids of lower socioeconomic status are being increasingly left behind.
Euan Ashley, professor of medicine and genetics, tells the stories of his patients with rare or mystery diseases through his new book, The Genome Odyssey.
Stanford Medicine science writer Tracie White shares the origins of her new book that explores ME/CFS, family bonds, science, suffering, and much more.
Stanford researcher finds that inpatient psychiatric care helps long-term recovery rates for people with both mental illness and addiction.
Stanford scientists have found two genes associated with concussion. Screening football players and military might identify those at higher risk.
As part of the series,Breaking down diabetes, physician Randall Stafford provides a straightforward guide to medications that can treat Type 2 diabetes.
Metformin is physician-researcher Randall Stafford's go-to drug for diabetes. He explains why in this installment in the series, Breaking down diabetes.
Early in the pandemic, COVID-19's blow to the economy was widespread, but deaths were concentrated geographically and by age group.
Technology that sends blood sugar-level updates to their smartphones improves outcomes for young people with type 1 diabetes, a Stanford trial shows.
A team of Stanford undergraduates designed a device that uses blue-light imaging technology to diagnose a parasitic disease called river blindness.
A Stanford researcher discusses how toxic pollutants can make people more susceptible to COVID-19 and why people of color are particularly vulnerable.
People taking two common types of drugs for hypertension are at no heightened risk, as has been feared, for increased severity or complications of COVID-19.
